Drug patent row: US firm files appeal against interim order

US pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High Court challenging its single bench order refusing to grant interim relief to it on a patent row against Indian firm Glenmark Pharmaceuticals.

Patent row: HC refuses interim relief to US drug firm Merck

Merck & Co sued Mumbai-based Glenmark for infringing on its patents for two diabetes drugs Januvia and Janumet.